Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Geyer S, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Bergsagel PL, Stewart AK, Rajkumar SV.
Lacy MQ, et al. Among authors: geyer s.
Mayo Clin Proc. 2007 Oct;82(10):1179-84. doi: 10.4065/82.10.1179.
Mayo Clin Proc. 2007.
PMID: 17908524